1. Home
  2. DUOT vs EOLS Comparison

DUOT vs EOLS Comparison

Compare DUOT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$9.00

Market Cap

264.5M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.30

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUOT
EOLS
Founded
1990
2012
Country
United States
United States
Employees
39
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.5M
284.3M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
DUOT
EOLS
Price
$9.00
$5.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$15.50
AVG Volume (30 Days)
418.3K
668.9K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
53.96
1.23
EPS
N/A
N/A
Revenue
$27,023,651.00
$297,176,000.00
Revenue This Year
$50.98
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
271.16
11.61
52 Week Low
$5.78
$3.86
52 Week High
$12.17
$12.24

Technical Indicators

Market Signals
Indicator
DUOT
EOLS
Relative Strength Index (RSI) 61.49 63.37
Support Level $8.89 $4.02
Resistance Level $9.60 $5.52
Average True Range (ATR) 0.52 0.25
MACD 0.08 0.07
Stochastic Oscillator 74.45 84.17

Price Performance

Historical Comparison
DUOT
EOLS

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: